← Open Payments lookup

KAITLIN KING: Open Payments

NPI 1801325162 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$900 in 42 payments from 13 companies in 2025. Trend: 2023 $863 · 2024 $1,345 · 2025 $900

Food & beverage: $900
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$255
Novo Nordisk Inc11$183
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$92
Aimmune Therapeutics, Inc.3$71
PFIZER INC.4$67
ABBVIE INC.2$58
Boston Scientific Corporation1$43
Lilly USA, LLC2$37
Astellas Pharma US Inc1$30
Exact Sciences Corporation1$19

Products named: FARXIGA, XIFAXAN, AIRSUPRA, ZENPEP, Ozempic, Rybelsus, NURTEC ODT, Wegovy.

Industry payments across AZ — which companies pay providers there.